Polo Like Kinase 4 (PLK4) impairs human bone marrow mesenchymal stem cell (BMSC) viability and osteogenic differentiation-Reference-Cited by-同舟云学术

Polo Like Kinase 4 (PLK4) impairs human bone marrow mesenchymal stem cell (BMSC) viability and osteogenic differentiation

Published:2021-04 Issue: Volume:549 Page:221-228
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Zhou Bin^ORCID,Peng Kun,Wang Guoqiang,Chen Weihua,Kang Yijun

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference39 articles.

1. Diagnosis and management of osteoporosis in the older senior;Vondracek;Clin. Interv. Aging,2009

2. Osteoclast differentiation and activation;Boyle;Nature,2003

3. Mesenchymal stem cells: progress toward promise;Le Blanc;Cytotherapy,2005

4. Multilineage potential of adult human mesenchymal stem cells;Pittenger;Science,1999

5. Regulatory effect of miRNA on multi-directional differentiation ability of mesenchymal stem cell in treatment of osteoporosis;Teng;J. Biol. Regul. Homeost. Agents,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient expansion and delayed senescence of hUC-MSCs by microcarrier–bioreactor system;Stem Cell Research & Therapy;2023-10-04

2. Inhibition of LPS‑induced NLRP3 inflammasome activation by stem cell‑conditioned culture media in human gingival epithelial cells;Molecular Medicine Reports;2023-04-05

3. Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs;International Journal of Molecular Sciences;2023-02-14

4. Titanium dioxide nanotubes increase purinergic receptor P2Y6 expression and activate its downstream PKCα-ERK1/2 pathway in bone marrow mesenchymal stem cells under osteogenic induction;Acta Biomaterialia;2023-02

5. Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients;Journal of Pediatric Hematology/Oncology;2022-08-11